The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways
Hossein Tezval*, Steffanie Jurk, Farahnaz Atschekzei, Jürgen Serth, Markus A. Kuczyk, Axel S. Merseburger
Dive into the research topics of 'The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways'. Together they form a unique fingerprint.